About Onkologie up2date

Onkologie up2date

Onkologie up2date is the continuing-education journal for oncology published by the Georg Thieme Verlag in Stuttgart. Launched in 2019 as one of three new up2date titles alongside Geriatrie up2date and Neurologie up2date, it informs oncologically active internists and assistant physicians in oncology training about advances in their specialty. Four times a year it delivers practice-relevant continuing-education articles with explanatory case examples and concrete recommendations for action, each issue built around four certified CME articles that earn readers three CME points apiece.

Overview

Onkologie up2date is a quarterly German-language CME journal from the Thieme up2date family, the publisher's line of curriculum-based continuing-education journals. The journal's programme is practice-oriented: continuing-education contributions from the whole of oncology, updated systematically so that readers stay automatically current. Every issue contains four certified CME articles, complemented by practice-oriented SOPs, step-by-step guides and summaries of international studies. All CME contributions pass through peer review and are didactically prepared; the underlying curriculum guarantees that all relevant areas of the specialty are covered systematically. With each of the four articles the reader can earn three CME points by correctly answering the associated multiple-choice questions — twelve points per issue, 48 per year. The didactic preparation is the journal's hallmark: a clear structure within the contributions, meaningful illustrations and tables, memory hooks, and step-by-step instructions for new and established methods and techniques. A free trial issue is offered, and the journal is available through the Thieme webshop with institutional pricing for hospitals and larger practices.

History

In May 2019 the Georg Thieme Verlag announced three new continuing-education journals in Stuttgart: Onkologie up2date, Geriatrie up2date and Neurologie up2date, each appearing four times a year. The launch extended the up2date series — which had already proven the concept of didactically prepared, curriculum-based CME journals — into three more specialties. Onkologie up2date was positioned for oncologically active internists and assistant physicians in oncology training, a readership that faces one of medicine's fastest-moving knowledge frontiers: new targeted therapies, immunotherapies and CAR-T cell therapies arriving faster than any individual physician can track. The journal's programme from the start emphasized the practice-relevant continuing-education article with explanatory case examples and concrete recommendations: understandable step-by-step instructions, clear structures, strong illustrations. The 2022 volume (volume 4) already carried the study-summary format on international research — for example the ESMO cancer-mortality projections for the EU — showing the journal's integration into the global oncology discourse. The abstract's focus — the ten leading causes of cancer death across 27 EU countries and the UK, with ovarian cancer as the special lens — illustrates the format: the international society's data, distilled into the continuing-education article, with the Thieme didactic preparation making the epidemiology readable for the practising oncologist. The Thieme Connect e-journal hosts the abstracts with DOIs in the 10.1055/a series, documenting the journal's continuous quarterly publication.

Coverage and Content

The CME contributions cover the whole of clinical oncology from the internist-oncologist's perspective: diagnosis, systemic therapy, supportive care and survivorship. The study summaries keep readers connected to the international literature — the September 2022 summary, for instance, reported the European Society for Medical Oncology's regular calculation of cancer mortality in the EU, covering the ten leading causes of cancer death in 27 EU countries and the UK with a special focus on ovarian cancer. The step-by-step instructions translate new and established methods into sequential procedures; the SOPs give oncology teams directly applicable workflows for quality assurance. The case examples anchor the knowledge in clinical reality: the didactic concept pairs the evidence with the patient story, the memory hooks with the clear structure. This is the journal's answer to the oncologist's central working problem: the gap between the trial result and the treatment decision. Where the primary literature reports the hazard ratio, Onkologie up2date reports what to do on Monday morning — which patients, which sequence, which dose adjustments, which supportive measures. The SOPs extend this into the team: the workflows that let the oncology ward, the day clinic and the practice deliver the same quality-assured care. The study summaries serve the time-pressed reader who cannot follow the international journals in full: the ESMO mortality projections, the pivotal trial readouts, distilled into the key messages with the journal's didactic preparation. The curriculum guarantees that the assistant physician in training encounters every relevant area systematically — not just the headline immunotherapies but the supportive care, the survivorship, the palliative integration that complete the oncologist's competence. The journal's curriculum guarantees systematic coverage of all relevant areas — the solid tumours, the hematologic malignancies, the supportive and palliative dimensions — so that the assistant physician in training builds the complete knowledge base issue by issue. The CME testing through the Thieme CME portal lets readers earn, submit and manage their points, with the multiple-choice questions testing the articles' key messages.

Organization and Ownership

Onkologie up2date is published by the Georg Thieme Verlag KG in Stuttgart (Rüdigerstraße 14, 70469 Stuttgart), one of Germany's leading medical and science publishers. The journal is part of Thieme's up2date continuing-education line, which applies the same curriculum-based, peer-reviewed, didactically prepared model across specialties from neurology to oncology to geriatrics. The 2019 launch announcement positioned the three new titles as the publisher's answer to the mandatory continuing education of physicians, which requires high-quality, current specialist information. The commercial model is the subscription journal: private subscriptions, institutional licences for hospitals and larger practices, and free trial issues as the acquisition funnel. CME points are earned and managed through the Thieme CME portal. The journal's content is also available through eRef, Thieme's knowledge portal for physicians, and through Thieme Connect, where the abstracts carry the journal's research summaries into the wider scientific record. Detailed editorial-board information is not publicly confirmed in the sources available.

Digital Presence

The journal's digital home is the Thieme journal page and Thieme Connect, which hosts the e-journal with abstracts and DOIs — the September 2022 ESMO mortality-projection summary (DOI 10.1055/a-1868-3076) illustrates the format. The Thieme CME portal is where readers earn their points: the multiple-choice tests for each of the four articles per issue, the point management, the submission to the medical chambers. The eRef portal makes the contributions available digitally, and the publisher's webshop handles subscriptions and trial issues. The 2019 launch press release on thieme.com documents the journal's positioning within the up2date family. In the German oncology media landscape — alongside Springer's "Die Onkologie" (formerly Der Onkologe) and the "InFo Hämatologie + Onkologie" training magazine — Onkologie up2date occupies the systematic-training pole: the quarterly journal that turns the specialty's accelerating knowledge into the internist-oncologist's competence, four times a year, in print and digital, from Stuttgart. Launched in May 2019 as one of three new up2date titles, it filled the gap between the scientific journals that publish the trials and the CME portals that test the knowledge: the journal that teaches the specialty systematically, with the curriculum as the syllabus, the case example as the method and the CME point as the reward. For the oncologically active internists and the assistant physicians in oncology training — the readership the 2019 launch announcement named — it remains the training companion for one of medicine's fastest-moving fields: four issues a year, four CME articles per issue, twelve points per issue, and the complete oncology curriculum, issue by issue, from the Thieme house in Stuttgart.